Administration of AICAR, an AMPK Activator, Prevents and Reverses Diabetic Polyneuropathy (DPN) by Regulating Mitophagy
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms26010080 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Krish Chandrasekaran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Hauptthemen laut MEDLINE: Aminoimidazole Carboxamide, Ribonucleotides, Diabetic Neuropathies, Mitophagy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Office of Research Development, Department of Veterans Affairs (Biomedical and Laboratory Research Service and Rehabilitation Research and Development).
Abstract (Originalsprache)
Diabetic peripheral neuropathy (DPN) is a common complication of diabetes in both Type 1 (T1D) and Type 2 (T2D). While there are no specific medications to prevent or treat DPN, certain strategies can help halt its progression. In T1D, maintaining tight glycemic control through insulin therapy can effectively prevent or delay the onset of DPN. However, in T2D, overall glucose control may only have a moderate impact on DPN, although exercise is clearly beneficial. Unfortunately, optimal exercise may not be feasible for many patients with DPN because of neuropathic foot pain and poor balance. Exercise has several favorable effects on health parameters, including body weight, glycemic control, lipid profile, and blood pressure. We investigated the impact of an exercise mimetic, 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), on DPN. AICAR treatment prevented or reversed experimental DPN in mouse models of both T2D and T1D. AICAR in high-fat diet (HFD-fed) mice increased the phosphorylation of AMPK in DRG neuronal extracts, and the ratio of phosphorylated AMPK to total AMPK increased by 3-fold (HFD vs. HFD+AICAR; p < 0.001). Phospho AMP increased the levels of dynamin-related protein 1 (DRP1, a mitochondrial fission marker), increased phosphorylated autophagy activating kinase 1 (ULK1) at Serine-555, and increased microtubule-associated protein light chain 3-II (LC3-II, a marker for autophagosome assembly) by 2-fold. Mitochondria isolated from DRG neurons of HFD-fed had a decrease in ADP-stimulated state 3 respiration (120 ± 20 nmol O2/min in HFD vs. 220 ± 20 nmol O2/min in control diet (CD); p < 0.001. Mitochondria isolated from HFD+AICAR-treated mice had increased state 3 respiration (240 ± 30 nmol O2/min in HFD+AICAR). However, AICAR’s protection in DPN in T2D mice was also mediated by its effects on insulin sensitivity, glucose metabolism, and lipid metabolism. Drugs that enhance AMPK phosphorylation may be beneficial in the treatment of DPN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- Veterans Affairs Medical Center, Baltimore, MD 21201, USA.
- CAMC Department of Neurology, Institute for Academic Medicine, 415 Morris Street Suite 300, Charleston, WV 25301, USA.
- West Virginia University, Charleston, WV 25301, USA.
ORCID-Profile: Krish Chandrasekaran, Ahmad F Hedayat, James W Russell
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
- Office of Research Development, Department of Veterans Affairs (Biomedical and Laboratory Research Service and Rehabilitation Research and Development)
- Diabetes Action Research and Education Foundation
- Atlantic Nutrition Obesity Research Center
Zitieren
APA
Chandrasekaran, K., Choi, J., Salimian, M., Hedayat, A. F., & Russell, J. W. (2024). Administration of AICAR, an AMPK Activator, Prevents and Reverses Diabetic Polyneuropathy (DPN) by Regulating Mitophagy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010080
Vancouver
Chandrasekaran K, Choi J, Salimian M, Hedayat AF, Russell JW. Administration of AICAR, an AMPK Activator, Prevents and Reverses Diabetic Polyneuropathy (DPN) by Regulating Mitophagy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010080
BibTeX
@article{Chandrasekaran2024,
author = {Chandrasekaran, Krish and Choi, Joungil and Salimian, Mohammad and Hedayat, Ahmad F and Russell, James W},
title = {Administration of AICAR, an AMPK Activator, Prevents and Reverses Diabetic Polyneuropathy (DPN) by Regulating Mitophagy},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms26010080}
}
EUVIMED